Mexidol® for arterial hypertension (AG). AH and cognitive disorders, effective correction methods

Time codes:
  • 00:00

    Arterial hypertension and its effect on the brain, Mexidol® with hypertension

  • 00:20

    Signs of brain damage to arterial hypertension

  • 01:07

    Correction of risk factors to improve cognitive functions

  • 02:16

    The role of the drug Mexidol® for cognitive impairment

Ostroumova Olga Dmitrievna - MD, professor, head. Department of Therapy and Polymorbid Pathology. Academician M.S. VLUSSi FSBEI DPO RMANPO of the Ministry of Health of Russia

Announcement:

Increased blood pressure is the main factor of high risk of premature death, brain stroke, myocardial infarction and other cardiovascular complications.

The most vulnerable blending organ with arterial hypertension is the brain.

The clinical manifestation of brain damage as an organ-target of arterial hypertension is cognitive impairment-such as impaired memory and attention. Thus, cognitive disorders are due to the manifestation of hypertension. To optimize antihypertensive therapy, in addition to basic drugs, neurometabolic drugs must be included in therapy and it is advisable to choose those that, as part of one tablet, realize several effects. Such a drug is Mexidol ® . It has a membranestabilizing and antioxidant effect, and also improves brain perfusion, which is extremely important for arterial hypertension. Proper basic therapy and the correct additional drug with a multimodal action mechanism provide maximum improvement in cognitive functions, and, therefore, the quality of life of patients.

Find out more in the video " Brain - a target of arterial hypertension ."

Block of articles on this topic

International multicenteric randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250 (study of memo): Subanalysis results in patients with arterial hypertension

Authors:
V.V. Zakharov 1 , O.D. Ostroumova 1.2 , A.I. Kochetkov 2 , M.V. Klepikov 2 , A.I. Fedin 3

Resolution of the Council of Experts "The possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders"
The possibilities of multimodal neuroprotection in patients with chronic brain ischemia against the background of arterial hypertension and atherosclerosis

Authors:
I.A. Gribacheva, T.F. Popova, E.V. Petrova, A.V. Zvonkova

FSBEI in Novosibirsk State Medical University of the Ministry of Health of Russia

Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. Ostroumova, A.I. Kochetkov, N.A. Shatalova

Cognitive disorders of vascular genesis in the practice of the therapist

Author:
P.R. Kamchatnov 1 , R.A. Cheremin 2 , L.A. Scepterova 2 , A.V. Chugunov 1

1 FGAOU in Russian National Medical University named after N.I. Pirogova ”of the Ministry of Health of Russia, Moscow
2 GBUZ“ Center for Pathology of Speech and Neurorebition of the Department of Health of the city of Moscow ”

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com